A prospective study of gynecological cancer risk in relation to adiposity factors: Cumulative incidence and association with plasma adipokine levels

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Wu, Meei Maan ^a,b,c   Chen, Hui Chi ^b   Chen, Chi Ling ^a   You, San Lin ^b   Cheng, Wen Fang ^a,d   Chen, Chi An ^d   Lee, Te Chang ^e   Chen, Chien Jen ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE;

ADULT; AGED; BLOOD; CASE CONTROL STUDY; COMPLICATION; FEMALE; FOLLOW UP; GENITAL NEOPLASMS, FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDY; RISK; TAIWAN; VERY ELDERLY;

ADIPOKINES; ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; OBESITY; ODDS RATIO; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK; TAIWAN;

EID: 84905844146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104630     Document Type: Article

References (42)

1. IARC (2007) Cancer incidence in five continents. International Agency for Research on Cancer IX.
2. Lin CH, Chen YC, Chiang CJ, Lu YS, Kuo KT, et al. (2012) The emerging epidemic of estrogen-related cancers in young women in a developing Asian country. Int J Cancer 130: 2629-2637.
3. BOHP (2008) Cancer registry annnual report, 2008. Taiwan. Department of Health, The Executive Yuan, Taiwan.
4. Cramer DW (2012) The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am 26: 1-12.
5. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE (2009) Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 114: 121-127.
6. Reeves GK, Pirie K, Beral V, Green J, Spencer E, et al. (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335: 1134.
7. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-591. (Pubitemid 39025053)
8. Setiawan VW, Monroe KR, Goodman MT, Kolonel LN, Pike MC, et al. (2008) Alcohol consumption and endometrial cancer risk: the multiethnic cohort. Int J Cancer 122: 634-638. (Pubitemid 350308957)
9. Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A (2009) Serum lipids and endometrial cancer risk: results from the HUNT-II study. Int J Cancer 124: 2938-2941.
10. Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, et al. (2009) Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 101: 296-305.
11. Bjorge T, Stocks T, Lukanova A, Tretli S, Selmer R, et al. (2010) Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 171: 892-902.
12. Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, et al. (2006) Ovarian cancer. Crit Rev Oncol Hematol 60: 159-179. (Pubitemid 44636248)
13. Mok SC, Kwong J, Welch WR, Samimi G, Ozbun L, et al. (2007) Etiology and pathogenesis of epithelial ovarian cancer. Dis Markers 23: 367-376. (Pubitemid 350171265)
14. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, et al. (1979) "Incessant ovulation" and ovarian cancer. Lancet 2: 170-173.
15. Canchola AJ, Chang ET, Bernstein L, Largent JA, Reynolds P, et al. (2010) Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort. Cancer Causes Control 21: 2241-2248.
16. Lahmann PH, Cust AE, Friedenreich CM, Schulz M, Lukanova A, et al. (2010) Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126: 2404-2415.
17. Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, et al. (2007) Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43: 690-709. (Pubitemid 46502901)
18. Galic S, Oakhill JS, Steinberg GR (2010) Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316: 129-139.
19. Ashizawa N, Yahata T, Quan J, Adachi S, Yoshihara K, et al. (2010) Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol 119: 65-69.
20. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, et al. (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88: 993-997. (Pubitemid 36337745)
21. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, et al. (2007) Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab 92: 255-263. (Pubitemid 46067541)
22. Luhn P, Dallal CM, Weiss JM, Black A, Huang WY, et al. (2013) Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 22: 1304-1312.
23. Chen CJ, Yang HI, Su J, Jen CL, You SL, et al. (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73. (Pubitemid 43042691)
24. Chen HC, Schiffman M, Lin CY, Pan MH, You SL, et al. (2011) Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst 103: 1387-1396.
25. Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145: 72-80. (Pubitemid 27009060)
26. WHO (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163.
27. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, et al. (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123: 2292-2333.
28. Rockhill B, Weinberg CR, Newman B (1998) Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. Am J Epidemiol 147: 826-833. (Pubitemid 28243454)
29. Ma X, Beeghly-Fadiel A, Shu XO, Li H, Yang G, et al. (2013) Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women's Health Study. Br J Cancer 109: 751-755.
30. Niwa Y, Yatsuya H, Tamakoshi K, Nishio K, Kondo T, et al. (2005) Relationship between body mass index and the risk of ovarian cancer in the Japanese population: findings from the Japanese Collaborate Cohort (JACC) study. J Obstet Gynaecol Res 31: 452-458. (Pubitemid 41607094)
31. Purohit V (1998) Moderate alcohol consumption and estrogen levels in postmenopausal women: a review. Alcohol Clin Exp Res 22: 994-997.
32. Zhang Y, Liu Z, Yu X, Zhang X, Lu S, et al. (2010) The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol 117: 41-46.
33. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946. (Pubitemid 32756432)
34. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638. (Pubitemid 36459468)
35. Schouten LJ, Rivera C, Hunter DJ, Spiegelman D, Adami HO, et al. (2008) Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 17: 902-912. (Pubitemid 351536422)
36. Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I (2008) Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol 136: 74-77.
37. Rzepka-Gorska I, Bedner R, Cymbaluk-Ploska A, Chudecka-Glaz A (2008) Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women. Eur J Gynaecol Oncol 29: 594-597.
38. Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, et al. (2010) Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev 29: 641-653.
39. Sharma D, Wang J, Fu PP, Sharma S, Nagalingam A, et al. (2010) Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology 52: 1713-1722.
40. Yang HP, Trabert B, Murphy MA, Sherman ME, Sampson JN, et al. (2012) Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study. Int J Cancer 131: 938-948.
41. Collaborative (2012) Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med 9: e1001200.
42. Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, et al. (2013) Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer 20: 251-262.